INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 226 filers reported holding INSMED INC in Q4 2022. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,775,959 | +67.2% | 70,335 | +39.7% | 0.79% | +64.8% |
| Q2 2023 | $1,062,069 | +23.8% | 50,335 | 0.0% | 0.48% | +36.0% |
| Q1 2023 | $858,212 | -88.8% | 50,335 | -87.3% | 0.35% | -67.5% |
| Q4 2022 | $7,635,000 | 0.0% | 397,169 | 0.0% | 1.09% | -35.4% |
| Q3 2022 | $7,635,000 | 0.0% | 397,169 | 0.0% | 1.68% | +93.6% |
| Q2 2022 | $7,635,000 | – | 397,169 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $100,415,822 | 8.32% |
| Deep Track Capital, LP | 6,500,000 | $110,825,000 | 4.55% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,932,138 | $49,992,953 | 2.11% |
| Endurant Capital Management LP | 230,006 | $3,921,602 | 2.01% |
| Ikarian Capital, LLC | 485,000 | $8,269,250 | 1.88% |
| MPM BioImpact LLC | 399,192 | $6,806,224 | 1.77% |
| SECTORAL ASSET MANAGEMENT INC | 516,092 | $8,799,369 | 1.69% |
| Novo Holdings A/S | 1,339,304 | $22,835,133 | 1.51% |
| First Light Asset Management, LLC | 750,883 | $12,802,555 | 1.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 143,794 | $2,451,688 | 1.01% |